Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
9.34B | 9.72B | 10.40B | 8.01B | 8.83B | 11.37B | Gross Profit |
9.14B | 9.72B | 10.40B | 8.01B | 8.83B | 11.37B | EBIT |
2.93B | 2.32B | 1.00B | -113.00M | 495.00M | 511.00M | EBITDA |
720.00M | 0.00 | 2.01B | 0.00 | 1.53B | 1.40B | Net Income Common Stockholders |
433.00M | 632.00M | 972.00M | 333.00M | 559.00M | 725.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
34.13B | 33.31B | 30.16B | 36.79B | 40.12B | 47.67B | Total Assets |
560.50B | 552.20B | 551.29B | 569.87B | 552.49B | 506.55B | Total Debt |
1.39B | 18.41B | 18.73B | 35.23B | 25.38B | 15.40B | Net Debt |
-32.74B | -33.31B | -11.43B | -1.55B | -14.74B | -32.27B | Total Liabilities |
531.12B | 520.89B | 5.23B | 537.55B | 518.90B | 475.71B | Stockholders Equity |
28.50B | 30.43B | 29.40B | 31.48B | 32.79B | 30.06B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.18B | -19.88B | 11.13B | 11.56B | -13.65B | Operating Cash Flow |
0.00 | 2.64B | -19.22B | 11.28B | 11.69B | -11.16B | Investing Cash Flow |
0.00 | 972.00M | 13.79B | -13.30B | -19.21B | 16.65B | Financing Cash Flow |
0.00 | -272.00M | -272.00M | -341.00M | -273.00M | -274.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $903.59B | 12.14 | 6.30% | 3.04% | 9.55% | 9.39% | |
71 Outperform | ¥332.37B | 10.33 | 1.85% | 21.04% | 20.47% | ||
70 Outperform | $727.43B | 11.98 | 6.00% | 3.43% | 15.35% | -1.62% | |
69 Neutral | $448.21B | 10.08 | 7.63% | 3.77% | -4.47% | 30.59% | |
68 Neutral | ¥52.26B | 5.44 | 3.52% | 17.59% | 44.54% | ||
64 Neutral | $12.60B | 9.73 | 7.92% | 16985.68% | 12.21% | -5.61% | |
61 Neutral | ¥8.23B | 8.54 | 3.30% | -10.59% | -44.94% |